- ICH GCP
- Rejestr badań klinicznych w USA
- Badanie kliniczne NCT07714408
The Effects of a Smartphone-Based Acceptance and Commitment Therapy Program on the Mental Health and Quality of Life of Caregivers Working in Long-Term Care Facilities
The Effects of a Smartphone-Based Acceptance and Commitment Therapy Program on the Mental Health and Quality of Life of Caregivers Working in Long-Term Care Facilities: A Randomized Controlled Trial Study
The aim of this study is to investigate whether a smartphone-based Acceptance and Commitment Therapy (ACT) program can improve the mental health and quality of life of care workers in long-term care facilities. The research question of this study is as follows: Among caregivers working in long-term care facilities, are there differences in mental health, quality of life, and job burnout between the experimental group that participated in a smartphone-based ACT program and the control group that participated in a document-based ACT program?
Participants in the experimental group will complete 70 daily sessions of a smartphone-based ACT program using Anzeilax-Plus, administered Monday through Friday over a 14-week period. Participants in the control group will complete 70 daily assignments from a document-based ACT program, administered Monday through Friday over the same 14-week period.
Przegląd badań
Status
Warunki
Typ studiów
Zapisy (Szacowany)
Faza
- Nie dotyczy
Kontakty i lokalizacje
Kontakt w sprawie studiów
- Nazwa: Woosang Hwang, Ph.D.
- Numer telefonu: 82-2-2077-7380
- E-mail: woosanghwang@sookmyung.ac.kr
Kryteria uczestnictwa
Kryteria kwalifikacji
Wiek uprawniający do nauki
- Dorosły
- Starszy dorosły
Akceptuje zdrowych ochotników
Opis
Inclusion Criteria:
- Caregivers aged 18 years or older who provide care services to older adults in long-term care facilities, own a smartphone, and have no history of depression or other mental illnesses.
Exclusion Criteria:
- Caregivers with a history of depression or other mental illnesses, or those who do not own a smartphone.
Plan studiów
Jak projektuje się badanie?
Szczegóły projektu
- Główny cel: Zapobieganie
- Przydział: Randomizowane
- Model interwencyjny: Przydział równoległy
- Maskowanie: Pojedynczy
Broń i interwencje
Grupa uczestników / Arm |
Interwencja / Leczenie |
|---|---|
|
Eksperymentalny: Mobile-based ACT group
One daily session of the smartphone-based ACT program delivered through the Anzeilax-Plus app
|
Participants will complete a daily Acceptance and Commitment Therapy (ACT) session through a mobile application on their smartphones.
|
|
Aktywny komparator: Document-based ACT group
One daily session of the document-based ACT program
|
Participants will complete a daily Acceptance and Commitment Therapy (ACT) session using materials provided by the research team.
|
Co mierzy badanie?
Podstawowe miary wyniku
Miara wyniku |
Opis środka |
Ramy czasowe |
|---|---|---|
|
Depressive symptoms
Ramy czasowe: From enrollment to Week 7 (mid-intervention) and Week 14 (end of the intervention)
|
Depressive symptoms will be measured using the Patient Health Questionnaire-9, a 9-item self-report measure.
Each item is rated on a 4-point scale, with total scores ranging from 9 to 36.
Higher scores indicate higher levels of depressive symptoms.
|
From enrollment to Week 7 (mid-intervention) and Week 14 (end of the intervention)
|
|
Anxiety
Ramy czasowe: From enrollment to Week 7 (mid-intervention) and Week 14 (end of the intervention)
|
Anxiety will be measured using the Generalized Anxiety Disorder-7, a 7-item self-report measure.
Each item is rated on a 4-point scale, with total scores ranging from 7 to 28.
Higher scores indicate higher levels of anxiety.
|
From enrollment to Week 7 (mid-intervention) and Week 14 (end of the intervention)
|
|
Stress
Ramy czasowe: From enrollment to Week 7 (mid-intervention) and Week 14 (end of the intervention)
|
Stress will be measured using the Perceived Stress Scale-10, a 10-item self-report measure.
Each item is rated on a 5-point scale, with total scores ranging from 10 to 50.
Higher scores indicate higher levels of stress.
|
From enrollment to Week 7 (mid-intervention) and Week 14 (end of the intervention)
|
|
Self-esteem
Ramy czasowe: From enrollment to Week 7 (mid-intervention) and Week 14 (end of the intervention)
|
Self-esteem will be measured using the Rosenberg Self-Esteem Scale, a 10-item self-report measure.
Each item is rated on a 5-point scale, with total scores ranging from 10 to 50.
Higher scores indicate higher levels of self-esteem
|
From enrollment to Week 7 (mid-intervention) and Week 14 (end of the intervention)
|
|
Job burnout
Ramy czasowe: From enrollment to Week 7 (mid-intervention) and Week 14 (end of the intervention)
|
Job burnout will be measured using the Maslach Burnout Inventory-General Survey, a 15-item self-report measure.
Each item is rated on a 5-point scale, with total scores ranging from 15 to 75.
Higher scores indicate higher levels of job burnout.
|
From enrollment to Week 7 (mid-intervention) and Week 14 (end of the intervention)
|
|
Quality of life (Psychological and physical well-being)
Ramy czasowe: From enrollment to Week 7 (mid-intervention) and Week 14 (end of the intervention)
|
Quality of life will be measured using the World Health Organization Quality of Life Scale a 15-item self-report measure.
Each item is rated on a 5-point scale, with total scores ranging from 15 to 75.
Higher scores indicate higher levels of quality of life.
|
From enrollment to Week 7 (mid-intervention) and Week 14 (end of the intervention)
|
Współpracownicy i badacze
Sponsor
Daty zapisu na studia
Główne daty studiów
Rozpoczęcie studiów (Szacowany)
Zakończenie podstawowe (Szacowany)
Ukończenie studiów (Szacowany)
Daty rejestracji na studia
Pierwszy przesłany
Pierwszy przesłany, który spełnia kryteria kontroli jakości
Pierwszy wysłany (Rzeczywisty)
Aktualizacje rekordów badań
Ostatnia wysłana aktualizacja (Rzeczywisty)
Ostatnia przesłana aktualizacja, która spełniała kryteria kontroli jakości
Ostatnia weryfikacja
Więcej informacji
Terminy związane z tym badaniem
Słowa kluczowe
Dodatkowe istotne warunki MeSH
Inne numery identyfikacyjne badania
- SMWU-2604-HR-020-01
- RS-2026-25477485 (Inny numer grantu/finansowania: National Research Foundation of Korea)
Plan dla danych uczestnika indywidualnego (IPD)
Planujesz udostępniać dane poszczególnych uczestników (IPD)?
Informacje o lekach i urządzeniach, dokumenty badawcze
Bada produkt leczniczy regulowany przez amerykańską FDA
Bada produkt urządzenia regulowany przez amerykańską FDA
Te informacje zostały pobrane bezpośrednio ze strony internetowej clinicaltrials.gov bez żadnych zmian. Jeśli chcesz zmienić, usunąć lub zaktualizować dane swojego badania, skontaktuj się z register@clinicaltrials.gov. Gdy tylko zmiana zostanie wprowadzona na stronie clinicaltrials.gov, zostanie ona automatycznie zaktualizowana również na naszej stronie internetowej .